Workshop 1

Research Focus: Investigating if the drug GG123 activates ERK (extracellular signal-regulated kinase) when introduced to hepatoma cells in culture.
Context: Hepatoma cells are derived from hepatic carcinomas, serving as useful preliminary models for liver studies due to their ease of cultivation in laboratory settings.

Signal Transduction Mechanisms: Effects are mediated by signaling cascades, essential for understanding cellular responses.

Definition: Reversible covalent modification is a method used to quickly regulate enzyme activity in response to cellular signals, notably hormones.
Forms of Modification: This can include various modifications such as prenylation, ubiquitination, and glycosylation. However, phosphorylation is the most common form.

Definition: Phosphorylation is the covalent addition of a phosphate group, typically transferred from ATP.
Enzymatic Roles:
- Kinases: Enzymes that catalyze the addition of phosphate groups to proteins.
- Phosphatases: Enzymes responsible for removing phosphate groups, thus reversing phosphorylation.
Functional Impact:
- Alters the three-dimensional conformation of target proteins due to the high charge density of the phosphoryl group (−2 at physiological pH).
- Facilitates the formation of salt bridges with nearby positively charged residues, such as Arginine or Lysine.

Mechanism: Kinases relay signals in cascades, where one kinase activates another, leading to a signal amplification.
Example Sequence:
- Receptor Tyrosine Kinase (RTK)
- Phosphorylation of the protein
- Activation of Ras
- Subsequent phosphorylations leading to the activation of ERK1/2.
- Final outcomes include cellular responses through substrates in cytosol and nucleus, influencing transcription.

Controls Needed:
- Vehicle Control: Essential to assess effects attributable to the solvent (e.g., DMSO) used to dissolve GG123.
- Structural Analogs: Sophisticated control via a variant of the drug without biological effects, offering insights into the specific mechanisms of GG123.

Initial Steps: Sequential processes are needed to prepare samples for kinase activity assays.
1. Cell Lysis: Breaking open cells while considering factors like lysosome integrity and membrane disruption.

Buffer Selection: A cold isotonic buffer is crucial to maintain protein structure and function during lysing.
Cold Temperature: Keeping samples cold prevents protein degradation.
Osmotic Balance: An isotonic buffer prevents organelle swelling and membrane damage.
pH: The buffer must be at physiological pH to maintain protein activity.
Protease and Phosphatase Inhibitors: To protect proteins from degradation and de-phosphorylation.
Detergent Use: Non-ionic detergents (e.g., Triton X100, Tween) help dissolve membranes without unwinding DNA, ensuring clean extracts.

Phospho-Specific Antibodies: Utilized to specifically detect ERK only when phosphorylated, as this denotes its activation state.

Design Workflow:
1. Incubate Samples: Biological samples alongside positive controls on a microplate coated with capture antibody.
2. Detection Antibody: Add phospho-specific or pan ERK antibody.
3. Secondary Antibody: Introduce an HRP-conjugated secondary antibody for signal amplification.
4. Substrate Addition: Add colorimetric substrate for visualizing kinase activity.
5. Analysis: Graph the results and perform data analysis.
Controls: Include technical replicates, consider protein load per well, and assess the impact of phosphatase treatment.

Biological Replicates: Represent measurements taken from biologically distinct samples to account for biological variation.
Technical Replicates: Provide repeated measures of the same sample that capture technical variation and equipment noise.

Ensures reproducibility and accuracy of data interpretation.
Example Application: Measuring levels of GG123 across multiple samples (e.g., liver biopsies from individual mice) to establish both technical and biological replicates, enhancing the reliability of results (with a defined limit of X technical and Y biological replicates).